Literature DB >> 8922739

Somatostatin sst2 receptor-mediated inhibition of parietal cell function in rat isolated gastric mucosa.

M A Wyatt1, E Jarvie, W Feniuk, P P Humphrey.   

Abstract

1. The aim of this study was to determine the location and functional characteristics of the somatostatin (SRIF) receptor type(s) which mediate inhibition of acid secretion in rat isolated gastric mucosa. 2. Gastrin (1 nM-1 microM), dimaprit (10 microM-300 microM) and isobutyl methylxanthine (IBMX, 1 microM-100 microM) all caused concentration-dependent increases in acid output. Responses to gastrin were almost completely inhibited by ranitidine (10 microM) at a concentration which abolished the secretory response to dimaprit. In contrast, responses to IBMX were not changed by ranitidine suggesting that IBMX acts directly on the parietal cell and not indirectly by releasing histamine from enterochromaffin-like (ECL) cells. 3. SRIF-14 (1 nM-1 microM) had no effect on basal acid output, but inhibited acid output produced by gastrin, dimaprit and IBMX in a concentration-dependent manner with respective EC50 values of 46, 54 and 167 nM. The peptidase inhibitors, amastatin (10 microM) and phosphoramidon (1 microM), had no effect on SRIF-induced inhibition of dimaprit stimulated gastric acid secretion. 4. The inhibitory effect of a range of SRIF analogues on gastrin-, dimaprit- and IBMX-induced acid secretion was also studied. Irrespective of the secretagogue used to increase acid output, the rank order of potencies was similar (BIM-23027 = seglitide = octreotide > SRIF-14 = SRIF-28 > L-362,855). The linear peptide BIM-23056 was devoid of agonist or antagonist activity in concentrations up to 1 microM. 5. The sst2 receptor selective peptides, BIM-23027, seglitide and octreotide were the most potent inhibitors of gastrin-, dimaprit- and IBMX-induced acid secretion suggesting that SRIF receptors resembling the recombinant sst2 receptors are involved. Furthermore, since dimaprit and IBMX stimulate gastric acid secretion independently of histamine release, sst2 receptor-mediated inhibition must occur at the level of the parietal cell itself.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8922739      PMCID: PMC1915956          DOI: 10.1111/j.1476-5381.1996.tb15758.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Differential effects of somatostatin and prostaglandins on gastric histamine release to pentagastrin.

Authors:  N A Payne; J G Gerber
Journal:  J Pharmacol Exp Ther       Date:  1992-11       Impact factor: 4.030

2.  Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5).

Authors:  Y C Patel; C B Srikant
Journal:  Endocrinology       Date:  1994-12       Impact factor: 4.736

3.  Comparative study of the control of basal acid output from rodent isolated stomachs.

Authors:  N J Welsh; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

4.  Cloning and expression of a novel mouse somatostatin receptor (SSTR2B).

Authors:  M Vanetti; M Kouba; X Wang; G Vogt; V Höllt
Journal:  FEBS Lett       Date:  1992-10-26       Impact factor: 4.124

5.  Inhibition by KF17837 of adenosine A2A receptor-mediated modulation of striatal GABA and ACh release.

Authors:  M Kurokawa; I P Kirk; K A Kirkpatrick; H Kase; P J Richardson
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

6.  Mediation by SRIF1 receptors of the contractile action of somatostatin in rat isolated distal colon; studies using some novel SRIF analogues.

Authors:  E S McKeen; W Feniuk; P P Humphrey
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

7.  Inhibitory action of somatostatin on cAMP dependent pepsinogen secretion from rat gastric chief cells: involvement of pertussis toxin-sensitive G-protein.

Authors:  T Tanaka; S Tani
Journal:  Biol Pharm Bull       Date:  1994-03       Impact factor: 2.233

8.  Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat.

Authors:  J F Bruno; Y Xu; J Song; M Berelowitz
Journal:  Endocrinology       Date:  1993-12       Impact factor: 4.736

9.  Characterization of somatostatin receptors in guinea-pig isolated ileum, vas deferens and right atrium.

Authors:  W Feniuk; J Dimech; P P Humphrey
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

10.  The somatostatin receptor subtype on rat enterochromaffinlike cells.

Authors:  C Prinz; G Sachs; J H Walsh; D H Coy; S V Wu
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

View more
  5 in total

1.  Role of somatostatin receptors on gastric acid secretion in wild-type and somatostatin receptor type 2 knockout mice.

Authors:  Laura Piqueras; Vicente Martínez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-11-20       Impact factor: 3.000

2.  Somatostatin-receptor 2 (sst2)-mediated effects of endogenous somatostatin on exocrine and endocrine secretion of the rat stomach.

Authors:  Vidar Fykse; David H Coy; Helge Lyder Waldum; Arne Kristian Sandvik
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

3.  Evidence that somatostatin sst2 receptors mediate striatal dopamine release.

Authors:  G J Hathway; P P Humphrey; K M Kendrick
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

4.  Control of gastric acid secretion in somatostatin receptor 2 deficient mice: shift from endocrine/paracrine to neurocrine pathways.

Authors:  Chun-Mei Zhao; Vicente Martinez; Laura Piqueras; Lixin Wang; Yvette Taché; Duan Chen
Journal:  Endocrinology       Date:  2007-11-01       Impact factor: 4.736

Review 5.  Adenosine: Direct and Indirect Actions on Gastric Acid Secretion.

Authors:  Rosa M Arin; Adriana Gorostidi; Hiart Navarro-Imaz; Yuri Rueda; Olatz Fresnedo; Begoña Ochoa
Journal:  Front Physiol       Date:  2017-09-22       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.